Collegium Pharmaceutical Inc [COLL] Insider Activity: An Update for Investors

In a filing, Collegium Pharmaceutical Inc revealed its Officer Smith Thomas B acquired Company’s shares for reported $0.67 million on Aug 29 ’25. In the deal valued at $38.42 per share,17,478 shares were bought.

Then, Dreyer Scott sold 16,389 shares, generating $626,171 in total proceeds. Upon selling the shares at $38.21, the EVP & Chief Commercial Officer now owns 103,613 shares.

Before that, SANTINI GINO sold 5,405 shares. Collegium Pharmaceutical Inc shares valued at $201,018 were divested by the Director at a price of $37.19 per share. As a result of the transaction, SANTINI GINO now holds 95,042 shares, worth roughly $3.69 million.

Needham upgraded its Collegium Pharmaceutical Inc [COLL] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in late July from “a Neutral” to “a Buy”. Jefferies also remained covering COLL and has increased its forecast on June 07, 2024 with a “Buy” recommendation from previously “Hold” rating. Piper Sandler revised its rating on May 10, 2024. It rated COLL as “a Neutral” which previously was an “an Overweight”.

Price Performance Review of COLL

On Friday, Collegium Pharmaceutical Inc [NASDAQ:COLL] saw its stock jump 1.17% to $38.8. Over the last five days, the stock has lost -0.79%. Collegium Pharmaceutical Inc shares have risen nearly 2.67% since the year began. Nevertheless, the stocks have risen 35.43% over the past one year. While a 52-week high of $42.29 was reached on 08/22/25, a 52-week low of $23.23 was recorded on 04/10/25.

Levels Of Support And Resistance For COLL Stock

The 24-hour chart illustrates a support level at 38.25, which if violated will result in even more drops to 37.70. On the upside, there is a resistance level at 39.10. A further resistance level may holdings at 39.41.

How much short interest is there in Collegium Pharmaceutical Inc?

A steep rise in short interest was recorded in Collegium Pharmaceutical Inc stocks on 2025-08-15, growing by 0.21 million shares to a total of 4.42 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 4.21 million shares. There was a rise of 4.8%, which implies that there is a positive sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.